Literature DB >> 24531703

Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor.

Shinji Mine1, Takeshi Sano, Naoki Hiki, Kazuhiko Yamada, Toshiyuki Kosuga, Souya Nunobe, Hironobu Shigaki, Toshiharu Yamaguchi.   

Abstract

BACKGROUND: It is difficult to determine preoperatively whether upper/middle thoracic lymphadenectomy is necessary in patients with adenocarcinoma of the esophagogastric junction (AEG) or lower esophageal squamous cell carcinoma (ESCC). Here, we investigated whether stratification based on the location of the proximal end of the tumor, as assessed using preoperative computed tomography (CT) images, would be useful for predicting upper/middle thoracic lymph node involvement for AEG and lower ESCC.
METHODS: A total of 142 patients with AEG and lower ESCC treated by R0-1 surgical resection via a thoracotomy was retrospectively investigated. The location of the proximal end of the tumor in comparison with the vena cava foramen (VCF) was decided by inspecting preoperative CT images and then correlated with upper/middle thoracic lymph node involvement.
RESULTS: The incidence of upper/middle thoracic lymph node involvement was low in AEG and ESCC tumors having proximal ends below the VCF (0 %, 0 of 13, and 5.9 %, 1 of 17, for AEG and ESCC, respectively). In contrast, when the tumors' proximal ends were above the VCF, patients had higher frequencies of upper/middle thoracic lymph node involvement (36.4 %, 8 of 22, and 37.8 %, 34 of 90, for AEG and ESCC, respectively). Multivariate analysis showed that the location of the proximal end of the tumor is an independent risk factor related to upper/middle thoracic lymph node involvement (odds ratio 14.3, 95 % confidence interval 1.76-111, p = 0.013), whereas other clinical factors (cT, cN, tumor length, and histologic types) are not.
CONCLUSIONS: This manner of stratification using preoperative CT images could be useful in deciding the extent of thoracic lymphadenectomy in both AEG and ESCC.

Entities:  

Mesh:

Year:  2014        PMID: 24531703     DOI: 10.1245/s10434-014-3548-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.

Authors:  Lei Huang; A-Man Xu; Qiang Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Adenocarcinoma of esophagogastric junction: controversial classification, surgical management, and clinicopathology.

Authors:  Lei Huang; A-Man Xu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

3.  Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Jian-Kun Hu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

4.  Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection.

Authors:  Hiroshi Saeki; Masayuki Watanabe; Shinji Mine; Hironobu Shigaki; Shuichiro Oya; Akiyoshi Ishiyama; Tomohiro Tsuchida; Junko Fujisaki; Hideo Baba; Yoshihiko Maehara; Takeshi Sano
Journal:  J Gastroenterol       Date:  2014-08-02       Impact factor: 7.527

5.  Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors.

Authors:  Akio Sakaki; Jun Kanamori; Koshiro Ishiyama; Daisuke Kurita; Junya Oguma; Hiroyuki Daiko
Journal:  Langenbecks Arch Surg       Date:  2020-06-08       Impact factor: 3.445

6.  Tumor location is an independent prognostic factor of esophageal adenocarcinoma based on the eighth edition of TNM staging system in Chinese patients.

Authors:  Han-Yu Deng; Xi Zheng; Guha Alai; Gang Li; Jun Luo; Ze-Guo Zhuo; Yi-Dan Lin
Journal:  Ann Transl Med       Date:  2019-08

Review 7.  Evidence-based approach to the treatment of esophagogastric junction tumors.

Authors:  Francisco Schlottmann; María A Casas; Daniela Molena
Journal:  World J Clin Oncol       Date:  2022-03-24

8.  Clinical Outcome of Intraoperative Recurrent Laryngeal Nerve Monitoring during Thoracoscopic Esophagectomy and Mediastinal Lymph Node Dissection for Esophageal Cancer.

Authors:  Chang-Lun Huang; Chun-Min Chen; Wei-Heng Hung; Ya-Fu Cheng; Ruei-Ping Hong; Bing-Yen Wang; Ching-Yuan Cheng
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.